Hsiao Lieu, EVP at NGM Biopharmaceuticals (NASDAQ:NGM), reported a large exercise of company stock options on November 8, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Lieu, EVP at NGM Biopharmaceuticals, a company in the Health Care sector, just exercised stock options worth 615,000 shares of NGM stock with an exercise price of $14.6.
NGM Biopharmaceuticals shares are trading up 5.0% at $0.92 at the time of this writing on Thursday morning. Since the current price is $0.92, this makes Lieu's 615,000 shares worth $563,524.
Now trade stocks online commission free with Charles Schwab, a trusted ...